Interleukin 21―Induced Granzyme B―Expressing B Cells Infiltrate Tumors and Regulate T Cells

• Published in: Cancer research (Chicago, Ill.) Ill.), 2013-04, Vol.73 (8), p.2468-2479
• Main Authors: LINDNER, Stefanie, DAHLKE, Karen, LUNOV, Oleg, NIENHAUS, G. Ulrich, SIMMET, Thomas, KREIENBERG, Rolf, MÖLLER, Peter, SCHREZENMEIER, Hubert, JAHRSDÖRFER, Bernd, SONTHEIMER, Kai, HAGN, Magdalena, KALTENMEIER, Christof, BARTH, Thomas F. E, BEYER, Thamara, REISTER, Frank, FABRICIUS, Dorit, LOTFI, Ramin
• Format: Article
• Language: English
• Subjects: Antineoplastic agents; Apoptosis - drug effects; B-Lymphocytes, Regulatory - drug effects; B-Lymphocytes, Regulatory - immunology; B-Lymphocytes, Regulatory - metabolism; Biological and medical sciences; CD5 Antigens - metabolism; Cell Communication - drug effects; Cells, Cultured; Granzymes - metabolism; Humans; Immunophenotyping; Interleukins - pharmacology; Lymphocyte Activation - drug effects; Lymphocyte Activation - immunology; Lymphocytes, Tumor-Infiltrating - drug effects; Lymphocytes, Tumor-Infiltrating - enzymology; Lymphocytes, Tumor-Infiltrating - immunology; Medical sciences; Neoplasms - enzymology; Neoplasms - immunology; Pharmacology. Drug treatments; Phenotype; Receptors, Antigen, T-Cell, gamma-delta - metabolism; Signal Transduction - drug effects; T-Lymphocyte Subsets - immunology; T-Lymphocyte Subsets - metabolism; Toll-Like Receptors - metabolism; Tumor Microenvironment - drug effects; Tumor Microenvironment - immunology; Tumors
• ISSN: 0008-5472; 1538-7445
• DOI: 10.1158/0008-5472.CAN-12-3450

The pathogenic impact of tumor-infiltrating B cells is unresolved at present, however, some studies suggest that they may have immune regulatory potential. Here, we report that the microenvironment of various solid tumors includes B cells that express granzyme B (GrB, GZMB), where these B cells can be found adjacent to interleukin (IL)-21-secreting regulatory T cells (Treg) that contribute to immune tolerance of tumor antigens. Because Tregs and plasmacytoid dendritic cells are known to modulate T-effector cells by a GrB-dependent mechanism, we hypothesized that a similar process may operate to modulate regulatory B cells (Breg). IL-21 induced outgrowth of B cells expressing high levels of GrB, which thereby limited T-cell proliferation by a GrB-dependent degradation of the T-cell receptor ζ-chain. Mechanistic investigations into how IL-21 induced GrB expression in B cells to confer Breg function revealed a CD19(+)CD38(+)CD1d(+)IgM(+)CD147(+) expression signature, along with expression of additional key regulatory molecules including IL-10, CD25, and indoleamine-2,3-dioxygenase. Notably, induction of GrB by IL-21 integrated signals mediated by surface immunoglobulin M (B-cell receptor) and Toll-like receptors, each of which were enhanced with expression of the B-cell marker CD5. Our findings show for the first time that IL-21 induces GrB(+) human Bregs. They also establish the existence of human B cells with a regulatory phenotype in solid tumor infiltrates, where they may contribute to the suppression of antitumor immune responses. Together, these findings may stimulate novel diagnostic and cell therapeutic approaches to better manage human cancer as well as autoimmune and graft-versus-host pathologies.